glp-1 vision changes Popular Weight Loss Drugs Linked to Risk of Sudden Loss Researchers Find Small Increased Risk

Demand for next-generation GLP-1 drugs is fueling a boom in peptide research, prompting companies like Sai Life Sciences to expand capabilities amid a hot market for obesity and diabetes treatments

Glp-1 (Glucagon Like Peptide) Single molecule made in the small intestine and colon Causes the pancreas to make insulin when sugar is in the blood stream, in a dose dependent fashion (the more sugar you have, the more GLP-1 tells the pancreas to release insulin) Tells the gastrointestinal tract to slow down digestion Slows down carbohydrate absorption (so your blood sugar doesnt escalate quickly) Curbs appetite Animal studies show GLP-1 may promote regeneration of the beta cells in the pancreas by fighting programmed cell death (apoptosis)

doi: 10.1016/S0968-0004(98)01224-9 56 SeigelT

Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF: Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis